Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers

Includes bibliographical references.

Saved in:
Bibliographic Details
Main Author: Dintwe, One Bridget
Other Authors: Scriba, Thomas J
Format: Thesis
Language:English
Published: Department of Paediatrics and Child Health 2014
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613299452936192
access_status_str Open Access
author Dintwe, One Bridget
author2 Scriba, Thomas J
author_browse Dintwe, One Bridget
Scriba, Thomas J
author_facet Scriba, Thomas J
Dintwe, One Bridget
author_sort Dintwe, One Bridget
collection Thesis
description Includes bibliographical references.
format Thesis
id oai:open.uct.ac.za:11427/8713
institution University of Cape Town (South Africa)
language eng
last_indexed 2026-06-10T12:33:55.830Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from UCTD — University of Cape Town Open Access Repository
publishDate 2014
publishDateRange 2014
publishDateSort 2014
publisher Department of Paediatrics and Child Health
publisherStr Department of Paediatrics and Child Health
record_format dspace
source_str UCTD — University of Cape Town Open Access Repository
spelling oai:open.uct.ac.za:11427/8713 Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers Dintwe, One Bridget Scriba, Thomas J Nemes, Elisa Includes bibliographical references. Tuberculosis (TB) remains a global health burden, with an estimated 1.3 million people dying from the disease in 2012. Protective immunity against TB is thought to depend on specific T cells. However, exactly which T cell characteristics are required for immunological protection is unknown. To gain a better understanding of M. tuberculosis (M.tb)-specific memory T cell immunity, we studied longevity and function of M.tb-specific memory T cells. We reasoned that such knowledge would facilitate rational vaccine design of a TB vaccine. We designed and developed a set of new HLA class II tetramers to perform in-depth studies of M.tb-specific CD4 T cell responses. We studied persons vaccinated with a novel TB vaccine, MVA85A, as well as persons naturally infected with M.tb. Antigen-specific CD4 T cells were detected with HLA class II tetramers and functional and phenotypic attributes of these T lymphocytes characterised by standard flow cytometric techniques. Comprehensive transcriptional analyses of M.tb-specific CD4 T cells, which were also sorted by FACS, were performed by microfluidic quantitative real-time PCR. Early after intradermal vaccination with MVA85A a large proportion of Ag85Aspecific CD4 T cells were highly activated, expressed skin homing markers and displayed an effector T cell phenotype. This effector response waned rapidly and gave way to antigen-specific central memory CD4 T cells with high proliferative potential, which we proposed may be desirable for protection. However, recent results from the first efficacy trial of MVA85A in infants suggested that these cells are not sufficient to enhance protection beyond that induced by BCG vaccination at birth. Further, we characterised surface marker expression and transcriptional signatures of a newly detected and described population of M.tb-specific CD4 T cells, that displayed a CD45RA+CCR7+CD27+ naïve-like T cell phenotype. We hypothesised that these unique M.tb-specific naïve-like CD4 T cells had a transcriptional profile distinct from truly naïve, central memory and effector bulk CD4 T cells, as well as other M.tb-specific memory CD4 T cell subsets. Gene expression of CFP10-specific naïve-like CD4 T cells reflected an mRNA profile that was very distinct from truly naïve bulk CD4 T cells. Rather, naïvelike CD4 T cells clustered with bulk effector CD4 T cells in unsupervised analysis methods such as hierarchical clustering and principle component analyses. Further analyses revealed that naïve-like CFP10-specific CD4 cells expressed mRNAs coding for effector cytokines, cytotoxic molecules and chemokine receptors consistent with effector memory T cells. However, the overall transcriptional profile was more similar to CFP10-specific central memory CD4 T cells than that of the effector CD4 T cells. We concluded that M.tb-specific naïve-like CD4 T cells may possess an ability to traffic to sites of infection or inflammation, where they may contribute to effector function. These hypotheses need confirmation on a protein level. The HLA class II tetramers developed in this thesis are valuabe tools for assessing direct ex vivo M.tb-specific CD4 T cell responses without activation and cell perturbation. Our findings contribute to a more comprehensive understanding of T cell immunity induced by vaccines and/or natural M.tb infection. 2014-10-21T13:53:54Z 2014-10-21T13:53:54Z 2014 Doctoral Thesis Doctoral PhD http://hdl.handle.net/11427/8713 eng application/pdf Department of Paediatrics and Child Health Faculty of Health Sciences University of Cape Town
spellingShingle Dintwe, One Bridget
Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
thesis_degree_str Doctoral
title Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
title_full Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
title_fullStr Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
title_full_unstemmed Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
title_short Characterisation of Mycobacterium tuberculosis specific T cell immunity with HLA class II tetramers
title_sort characterisation of mycobacterium tuberculosis specific t cell immunity with hla class ii tetramers
url http://hdl.handle.net/11427/8713
work_keys_str_mv AT dintweonebridget characterisationofmycobacteriumtuberculosisspecifictcellimmunitywithhlaclassiitetramers